Clinical Report: Exploring Racial Disparities in Follow-Up Treatment and Survival Rates for Localized Prostate Cancer
Overview
This study investigates racial disparities in secondary treatment and survival rates for localized prostate cancer, focusing on the differences in therapy receipt between Black and White men.
Background
Racial disparities in prostate cancer treatment and outcomes have been a persistent concern, particularly regarding the differences in therapy receipt between Black and White men. Previous studies have shown that Black men are less likely to receive definitive therapy. Understanding these disparities is crucial for improving equity in prostate cancer care.
Data Highlights
The study utilized the Medicare-SEER database, analyzing over 80,000 patients diagnosed between 2004 and 2017. Key findings include:
Key Findings
Secondary treatment receipt after primary definitive treatment was similar across races.
Black men exhibited features of higher-risk disease compared to White men.
Black men who did not receive secondary therapy had a higher risk of prostate cancer-specific mortality.
Black men were less likely to receive systemic therapy as a secondary treatment.
Disparities in care may be attributed to variations in the receipt of secondary treatments among Black patients.
Clinical Implications
Healthcare providers should be aware of the disparities in secondary treatment receipt among Black men with prostate cancer.
Conclusion
Further research into the factors contributing to racial disparities in prostate cancer treatment and outcomes is needed.
